青光眼睫状体炎综合征的临床特点与治疗预后情况探析

Clinical Characteristics and Prognosis of Posner-schlossman Syndrome

目的对青光眼睫状体炎综合征患者的临床特点以及其治疗预后情况进行分析。方法以青光眼睫状体炎综合征患者50例为研究对象,时间为2017年1月至2018年10月,对其临床资料分析,总结其疾病的临床特点、治疗、预后等情况。结果 50例青光眼睫状体炎综合征患者中,其治愈率为72. 00%(36例),经治疗后,眼压水平明显低于治疗前,其视力水平明显高于治疗前,差异有统计学意义(P<0. 05)。结论青光眼睫状体炎综合征患者接受眼压降低、抗炎等治疗干预,可有效促进其预后的改善。

Objective To analyze the clinical characteristics and prognosis of patients with Posner-Schlossman syndrome.Methods Clinical data of 50 patients with Posner-Schlossman syndrome were analyzed from January 2017 to October 2018,and the clinical characteristics,treatment and prognosis of the disease were summarized. Results The cure rate of 50 patients with PosnerSchlossman syndrome was 72. 00%( 36 cases). After treatment,the level of intraocular pressure was significantly lower than that before treatment. The visual acuity level was significantly higher than that before treatment. The difference is statistically significant( P<0. 05). Conclusion The prognosis of patients with Posner-Schlossman syndrome can be improved effectively by the intervention of intraocular pressure reduction and anti-inflammatory therapy.